December 3, 2014 | The California Institute for Regenerative Medicine and Israel’s Center for R&D, MATIMOP, will cooperate to advance stem cell research and regenerative medicine. The agreement, which will be signed on December 5th, lays out the foundation for a potential Californian-Israeli stem cell research programs, with the goal of making it easier for researchers to obtain funding. At the signing of the agreement in San Francisco, MATIMOP will be represented Michel Hivert. MATIMOP is the executive agency of the Office of the Chief Scientist and is the national agency for research and development in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments